Agilon Health Inc. logo

Agilon Health Inc.

AGL | NYSE
Chart Builder DCF Calculator
$90.19
+$2.16 (+2.45%)
Sep 22, 2026, 10:38 AM ET · Market open

Market Data

Market Cap
$1.47B
Enterprise Value
$1.32B
Beta
3.04
Average Volume
379.42K
Shares Outstanding (Diluted)
17.21M
Shares Change YoY
3.98%
Institutional Ownership
0.09%
Exchange
NYSE
ISIN
US00857U2069

Price Performance

Price Change 1M
-7.3%
Price Change 3M
-21.2%
Price Change 6M
724.3%
Price Change YTD
422.7%
Price Change 1Y
211.6%
Price Change 3Y
-80.9%
Price Change 5Y
-87.5%
1M CAGR (ann.)
-7.8%
1Y CAGR (ann.)
201.0%
5Y CAGR (ann.)
-35.7%
All-Time CAGR
-33.0%

Valuation

PE Ratio
-5.71
Forward PE
58.44
PEG Ratio
-1.47
Forward PEG
0.03
PS Ratio
0.25
Forward PS
0.20
PB Ratio
6.45
P/FCF Ratio
-13.07
P/Adj. FCF Ratio
-9.21
P/OCF Ratio
-20.33
EV/Sales
0.22
EV/EBIT
-5.02
EV/EBITDA
-5.63
EV/FCF
-11.71
Earnings Yield
-17.5%
FCF Yield
-7.7%
Adj. FCF Yield
-10.9%

Financial Health

Net Cash
$155.34M
Total Debt
$33.45M
Cash & Short-Term Investments
$185.63M
Total Assets
$1.59B
Current Ratio
1.08
Quick Ratio
1.08
Debt / Equity Ratio
0.15
Debt / EBITDA
-0.14
Debt / FCF
-0.30
OCF / Debt
-2.16
Interest Coverage
-79.13
Altman Z-Score
2.22
Piotroski F-Score
4

Margins & Profitability

Gross Profit Margin
0.0%
Operating Profit Margin
-4.5%
EBITDA Margin
-4.0%
Net Profit Margin
-4.2%
FCF Margin
-1.9%
Adj. FCF Margin
-2.7%
SBC / Revenue
0.8%
SBC Impact (per share)
-41.9%

Returns

Return on Assets
-15.8%
Return on Equity
-119.3%
Return on Invested Capital
-90.2%
Return on Capital Employed
-95.0%
Return on Tangible Assets
-16.4%

Historical Growth (CAGR)

Revenue CAGR 3Y
19.1%
Revenue CAGR 5Y
30.8%
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
8.0%
EPS CAGR 5Y
-23.7%
EPS CAGR 10Y
N/A
FCF CAGR 3Y
30.0%
FCF CAGR 5Y
15.4%
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
Hold
Analyst Count
25
EPS Growth Next 3Y
41.1%
Revenue Growth Next 3Y
9.7%
Earnings Date
Nov 2, 2026
EPS Estimate (next Q)
-$1.22
EPS Growth Est (next Q)
-81.9%
Revenue Est (next Q)
$1.46B
Revenue Growth Est (next Q)
1.5%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$94.22
Price Target Upside
7.0%

Cash Flow

Operating Cash Flow
$-72.26M
Free Cash Flow
$-112.38M
Adj. Free Cash Flow
$-159.48M
FCF Per Share
-$6.73
OCF Per Share
-$4.33
OCF/S Ratio
-1.2%

Income Statement

Revenue
$5.92B
Gross Profit
$82K
Operating Income
$-265.15M
EBITDA
$-234.01M
Net Income
$-251.16M
EPS (Diluted)
-$15.41
Revenue / Employee
$6.92M
Profit / Employee
$-293.41K
Employees
856

© 2026 bestshares.com. All rights reserved.